drugset / Trial / NCT00546520
Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)
RandomizedCrossoverDouble-blindPrevention
Summary
Ciclesonide is a novel inhaled corticosteroid for the treatment of asthma. In this study the effect of ciclesonide on airway hyperresponsiveness (AHR), exhaled nitric oxide (NO), and induced sputum inflammatory biomarkers will be evaluated.
Timeline
- Start
- 2002-04
- Primary completion
- 2002-06
- Completion
- 2002-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ciclesonide | Other / unclassified | 400 ug | Inhaled |
| Subject | Ciclesonide | Other / unclassified | 800 ug | Inhaled |